Human Naïve CD8+/CD45RA+ T Cells
Human Naïve CD8+/CD45RA+ T Cells
Human CD8+/CD45RA+ naïve cytotoxic T cells, isolated from peripheral blood using negative immunomagnetic selection, ≥ 5 million cells, cryopreserved
Product Overview
Naïve CD8+ T cells are isolated using a two step isolation process. CD8+ T Cells are first negatively selected from MNC obtained from leukapharesed blood using an indirect immunomagnetic CD8+ labeling system. CD45RO microbeads are then used to deplete the CD45RO+ population, leaving a highly enriched CD4+ CD45RA+ Naïve T Cell population.
Cells are cryopreserved in Lonza Cryo Media and collected in a cryovial. Cell purity is determined post thaw using a FACS assay. Count and viability is determined using hemacytometer (trypan blue method). Cells are collected from healthy donors following IRB protocols.
Request More InfoApplications
- Immunology research
- Vaccine development
- Adoptive cell transfer therapy
- Immune monitoring
- Immunosenescence research
Storage and Content
1 vial containing ≥ 5 million cryopreserved cells
SDS, CoA, and Instructions
Safety Data Sheets (SDS)
Choose a language to view the SDS.
Certificate of Analysis (CoA)
Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.